AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10396321 — intervention group
Group type: EXPERIMENTAL
Intervention: 5'-DFUR (800 mg daily for 3 weeks)
Number of subjects: 55
Study 10396321 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 55
Study 10396321 — intervention group
Group type: EXPERIMENTAL
Intervention: 5'-DFUR
Number of subjects: 55
Study 8839231 — intervention group
Group type: EXPERIMENTAL
Intervention: ITF 296
Number of subjects: 10
Study 8839231 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 10
Study 8839231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2123819 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein Hydrolysate (PH) diet
Number of subjects: 12
Study 2123819 — intervention group
Group type: COMPARATOR
Intervention: Non-Degraded Protein (NDP) diet
Number of subjects: 12
Study 6990948 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate with neostigmine
Number of subjects: 641
Study 6990948 — intervention group
Group type: COMPARATOR
Intervention: Atropine with neostigmine
Number of subjects: 641
Study 31651037 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoralen and narrowband UVB (P-NBUVB)
Number of subjects: 40
Study 31651037 — intervention group
Group type: COMPARATOR
Intervention: Narrowband UVB (NBUVB)
Number of subjects: 40
Study 30782674 — intervention group
Group type: EXPERIMENTAL
Intervention: Families First Programme (10 group sessions and four home visits over 3 months)
Number of subjects: 720
Study 30782674 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (standard community health and social services only)
Number of subjects: 720
Study 28705728 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct loading group A (n=81)
Number of subjects: 158
Study 28705728 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading group B (n=77)
Number of subjects: 158
Study 28705728 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups A and B
Number of subjects: 158
Study 25945662 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow diaphragmatic breathing (DB)
Number of subjects: 43
Study 25945662 — intervention group
Group type: COMPARATOR
Intervention: Control group (breathing naturally at a normal pace)
Number of subjects: 43
Study 23623841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 144
Study 23623841 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT)
Number of subjects: 144
Study 23623841 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study 21330285 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program
Number of subjects: 1112
Study 21330285 — intervention group
Group type: COMPARATOR
Intervention: Booklet smoking cessation program
Number of subjects: 1112
Study 21330285 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program (completed)
Number of subjects: 1112
Study 21330285 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program (not completed)
Number of subjects: 1112
Study 19095848 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 44
Study 19095848 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 44
Study 19095848 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of laryngoscope types
Number of subjects: 44
Study 19095848 — intervention group
Group type: EXPERIMENTAL
Intervention: Mallampati and Cormack-Lehane grades
Number of subjects: 44
Study 17167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment for primary and secondary prevention of CHD
Number of subjects: 0
Study 17167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol synthesis inhibition in the brain
Number of subjects: 0
Study 17167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of biomarkers linked to fatal CHD events
Number of subjects: 0
Study 17167280 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing lipid nutrition advice
Number of subjects: 0
Study 15519288 — intervention group
Group type: EXPERIMENTAL
Intervention: OTC lovastatin 20 mg
Number of subjects: 3300
Study 11302460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (20 minute cold pack application to the calf)
Number of subjects: 26
Study 11302460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 26
Study 9663360 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg QID for 4 weeks
Number of subjects: 287
Study 9663360 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 287
Study 9663360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study 8092897 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective vagotomy-antrectomy (SV-A)
Number of subjects: 200
Study 8092897 — intervention group
Group type: COMPARATOR
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 200
Study 3134859 — intervention group
Group type: EXPERIMENTAL
Intervention: MQF-OK therapy with UFT (group B)
Number of subjects: 80
Study 3134859 — intervention group
Group type: COMPARATOR
Intervention: MQF-OK therapy with FT (group A)
Number of subjects: 80
Study 31641534 — intervention group
Group type: EXPERIMENTAL
Intervention: AlterG device (LBPPSS)
Number of subjects: 50
Study 31641534 — intervention group
Group type: COMPARATOR
Intervention: Conventional treadmill gait training (TGT)
Number of subjects: 50
Study 31641534 — intervention group
Group type: EXPERIMENTAL
Intervention: AlterG device (LBPPSS) in healthy controls (HC)
Number of subjects: 50
Study 29931302 — intervention group
Group type: EXPERIMENTAL
Intervention: BBM e‐learning tool
Number of subjects: 79
Study 29931302 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 79
Study 25849415 — intervention group
Group type: EXPERIMENTAL
Intervention: Single repetition group (SS of short duration <30 sec)
Number of subjects: 40
Study 25849415 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple repetition group (SS of moderate duration)
Number of subjects: 40
Study 25849415 — intervention group
Group type: COMPARATOR
Intervention: Control trial (no stretches performed)
Number of subjects: 40
Study 24064510 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloxacillin + Amikacin
Number of subjects: 90
Study 24064510 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime + Gentamicin
Number of subjects: 90
Study 22406323 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Behavioral Assessment and Intervention Program (IBAIP)
Number of subjects: 176
Study 22406323 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 176
Study 20613777 — intervention group
Group type: EXPERIMENTAL
Intervention: UVR exposure in PLE patients
Number of subjects: 24
Study 20613777 — intervention group
Group type: COMPARATOR
Intervention: UVR exposure in healthy controls
Number of subjects: 24
Study 19046249 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention directed at a healthy diet and increased physical activity
Number of subjects: 0
Study 19046249 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 15531318 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (20 Gy delivered in 5 daily fractions of 4 Gy each; 6 MV)
Number of subjects: 88
Study 15531318 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy (sham radiotherapy or observation)
Number of subjects: 88
Study 11133599 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cementing technique
Number of subjects: 120
Study 11133599 — intervention group
Group type: COMPARATOR
Intervention: Modified cementing technique
Number of subjects: 120
Study 9753893 — intervention group
Group type: EXPERIMENTAL
Intervention: Drivers with cardiovascular diseases (sick drivers)
Number of subjects: 419
Study 9753893 — intervention group
Group type: COMPARATOR
Intervention: Healthy drivers (control group)
Number of subjects: 419
Study 8072721 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists in chronic haemodialysis patients
Number of subjects: 0
Study 8072721 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril, verapamil, and metoprolol in 5/6 nephrectomized rats
Number of subjects: 0
Study 8072721 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide in rats with streptozotocin-induced diabetes
Number of subjects: 0
Study 8072721 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment in normotensive patients with microalbuminuric diabetes or non-diabetic uraemic nephropathy
Number of subjects: 0
Study 8072721 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors in diabetic nephropathy and non-diabetic uraemic nephropathy
Number of subjects: 0
Study 2483115 — intervention group
Group type: EXPERIMENTAL
Intervention: Dithranol with 2% salicylic acid (D + S)
Number of subjects: 0
Study 2483115 — intervention group
Group type: COMPARATOR
Intervention: Dithranol in the same base without salicylic acid (D‐S)
Number of subjects: 0
Study 28978279 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced schedule
Number of subjects: 0
Study 28978279 — intervention group
Group type: COMPARATOR
Intervention: Massed schedule
Number of subjects: 0
Study 28375862 — intervention group
Group type: EXPERIMENTAL
Intervention: SBB attachments
Number of subjects: 10
Study 28375862 — intervention group
Group type: COMPARATOR
Intervention: Healing abutments
Number of subjects: 10
Study 28375862 — intervention group
Group type: COMPARATOR
Intervention: Conventional removable partial dentures (CRPDs)
Number of subjects: 10
Study 26598473 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational group intervention (PE)
Number of subjects: 89
Study 26598473 — intervention group
Group type: COMPARATOR
Intervention: Nonstructured group intervention (NS)
Number of subjects: 89
Study 24092750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 7863
Study 24092750 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in Lp(a) at 1 year
Number of subjects: 7863
Study 24092750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7863
Study 21166722 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream
Number of subjects: 20
Study 21166722 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone 0.1% cream
Number of subjects: 20
Study 18305467 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine with adjusted dosage to maintain trough levels of 60-80 ng/ml in Group A
Number of subjects: 0
Study 18305467 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine with fixed dosage of 2.5 mg/kg/day in Group B
Number of subjects: 0
Study 16597078 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (448 microg for 36 months)
Number of subjects: 103
Study 16597078 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (1,181 microg for 41 months)
Number of subjects: 103
Study 16597078 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (745 microg for 19 months)
Number of subjects: 103
Study 16597078 — intervention group
Group type: COMPARATOR
Intervention: Oral corticosteroids (positive control)
Number of subjects: 103
Study 12563621 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric measures (weight, stature, BMI, arm and calf circumference, triceps and subscapular skinfolds)
Number of subjects: 1000
Study 12563621 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric measures in patients with diabetes
Number of subjects: 1000
Study 12678512 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 40 mg I.M. with 20 mg chlorpheniramine maleate (CPM)
Number of subjects: 61
Study 12678512 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine maleate (CPM, 20 mg) I.M.
Number of subjects: 61
Study 9411330 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 20
Study 8409568 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble aspirin 600 mg tds
Number of subjects: 136
Study 8409568 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac dispersible 50 mg tds
Number of subjects: 136
Study 3954112 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral controlled release morphine (30 mg CRM orally)
Number of subjects: 20
Study 3954112 — intervention group
Group type: COMPARATOR
Intervention: Epidural morphine (4 mg morphine epidurally)
Number of subjects: 20
Study 30839263 — intervention group
Group type: EXPERIMENTAL
Intervention: Video game self-training (n = 13)
Number of subjects: 24
Study 30839263 — intervention group
Group type: COMPARATOR
Intervention: Traditional self-training (n = 11)
Number of subjects: 24
Study 30839263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study 29068725 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 66
Study 29068725 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 66
Study 29068725 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf muscle performance tests
Number of subjects: 66
Study 29068725 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel-rise height
Number of subjects: 66
Study 29068725 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon Total Rupture Score (ATRS)
Number of subjects: 66
Study 29068725 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Scale (PAS)
Number of subjects: 66
Study 26822799 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine augmentation of escitalopram
Number of subjects: 52
Study 26822799 — intervention group
Group type: COMPARATOR
Intervention: Placebo augmentation of escitalopram
Number of subjects: 52
Study 25102385 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-based therapy (ABT) for 24 weeks, 9h/wk including developmental sequencing, resistance training, repetitive, patterned motor activity, and task-specific locomotor training
Number of subjects: 38
Study 25102385 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-based therapy (ABT)
Number of subjects: 38
Study 22485232 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT-guided group (study group)
Number of subjects: 71
Study 22485232 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic antibiotic therapy (control group)
Number of subjects: 71
Study 20440025 — intervention group
Group type: EXPERIMENTAL
Intervention: TGMD-2
Number of subjects: 75
Study 19094762 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal extracorporeal circulation (MECC)
Number of subjects: 40
Study 19094762 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation (cECC)
Number of subjects: 40
Study 15083597 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin-fibrate combination therapy
Number of subjects: 0
Study 15083597 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin-niacin combination therapy
Number of subjects: 0
Study 15083597 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitors of cholesterol ester transfer protein and HDL therapy drugs
Number of subjects: 0
Study 10780713 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) administered orally, twice a day from 36 weeks' gestation until labor and every 3 hours during labor.
Number of subjects: 372
Study 10780713 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) group
Number of subjects: 372
Study 10780713 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 372
Study 9323348 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice of sustained perceptual, memory and motor tasks 5 times/week for 10 weeks
Number of subjects: 22
Study 9323348 — intervention group
Group type: COMPARATOR
Intervention: High functioning healthy controls (n = 5) given the same tasks at difficulty levels comparable to those achieved by patients after 10 weeks of practice
Number of subjects: 22
Study 9511601 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgaphase
Number of subjects: 82
Study 9511601 — intervention group
Group type: COMPARATOR
Intervention: Dispersalloy (Control)
Number of subjects: 82
Study 9511601 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalga 43
Number of subjects: 82
Study 9511601 — intervention group
Group type: EXPERIMENTAL
Intervention: Permite C
Number of subjects: 82
Study 3512944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 0.004 mg/kg
Number of subjects: 11
Study 3512944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 0.009 mg/kg
Number of subjects: 11
Study 3512944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine 0.013 mg/kg
Number of subjects: 11
Study 3512944 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 11
Study 3512944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (most effective dose)
Number of subjects: 11
Study 3512944 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 11
Study 30218228 — intervention group
Group type: EXPERIMENTAL
Intervention: bioactive glass‐ceramic powder/two‐step etch and rinse system
Number of subjects: 92
Study 30218228 — intervention group
Group type: COMPARATOR
Intervention: control/two‐step etch and rinse system
Number of subjects: 92
Study 30218228 — intervention group
Group type: EXPERIMENTAL
Intervention: bioactive glass‐ceramic powder/two‐step self‐etching system
Number of subjects: 92
Study 30218228 — intervention group
Group type: COMPARATOR
Intervention: control/two‐step self‐etching system
Number of subjects: 92
Study 29071985 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at phenomaxillary ganglia and local acupoints (Yingxiang (LI 20, bilateral) and Yintang (EX-HN 3)) for 20 min, twice per week for 4 weeks.
Number of subjects: 50
Study 29071985 — intervention group
Group type: COMPARATOR
Intervention: Oral loratadine tablets for 4 weeks.
Number of subjects: 50
Study 25344361 — intervention group
Group type: COMPARATOR
Intervention: PEB chemotherapy (cisplatin, etoposide, and bleomycin)
Number of subjects: 85
Study 25344361 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose sequential chemotherapy (HDS)
Number of subjects: 85
Study 25034387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100mg/d)
Number of subjects: 36
Study 22009480 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (blood alcohol level raised to .07%) with high sexual arousal (mildly erotic film clips)
Number of subjects: 117
Study 22009480 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (blood alcohol level raised to .07%) with low sexual arousal (non-erotic film clips)
Number of subjects: 117
Study 22009480 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo with high sexual arousal (mildly erotic film clips)
Number of subjects: 117
Study 22009480 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo with low sexual arousal (non-erotic film clips)
Number of subjects: 117
Study 22009480 — intervention group
Group type: COMPARATOR
Intervention: Water control with high sexual arousal (mildly erotic film clips)
Number of subjects: 117
Study 22009480 — intervention group
Group type: COMPARATOR
Intervention: Water control with low sexual arousal (non-erotic film clips)
Number of subjects: 117
Study 19620014 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 103
Study 19620014 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 103
Study 17530973 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) stretching, performed 3 times per week for 4 weeks
Number of subjects: 20
Study 17530973 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 15593364 — intervention group
Group type: EXPERIMENTAL
Intervention: 23 weeks of supervised aerobic exercise
Number of subjects: 29
Study 10730021 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (comprehensive drug therapy management program)
Number of subjects: 210
Study 10730021 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to pharmaceutical care)
Number of subjects: 210
Study 9174297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 20 microg + saline
Number of subjects: 22
Study 9174297 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal 5% lidocaine
Number of subjects: 22
Study 1359809 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (initial dose 170 ng.kg‐1 x min‐1, maintenance 10 ng.kg‐1 x min‐1)
Number of subjects: 34
Study 1359809 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 34
Study 3894971 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg
Number of subjects: 12
Study 3894971 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized meal after caffeine
Number of subjects: 12
Study 3894971 — intervention group
Group type: COMPARATOR
Intervention: Standardized meal without caffeine
Number of subjects: 12
Study 31518894 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one mentorship program
Number of subjects: 438
Study 31518894 — intervention group
Group type: COMPARATOR
Intervention: Basic preceptorship (Control)
Number of subjects: 438
Study 29567432 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a negative risk-reward relationship
Number of subjects: 352
Study 29567432 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a positive risk-reward relationship
Number of subjects: 352
Study 29567432 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to an uncorrelated risk-reward relationship
Number of subjects: 352
Study 26226891 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV)
Number of subjects: 8
Study 26226891 — intervention group
Group type: COMPARATOR
Intervention: Assist Control Ventilation (ACV)
Number of subjects: 8
Study 25099973 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral puncture group (n=36)
Number of subjects: 68
Study 25099973 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral group (n=32)
Number of subjects: 68
Study 23203140 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g soy protein and 100 mg isoflavones
Number of subjects: 180
Study 23203140 — intervention group
Group type: COMPARATOR
Intervention: 15 g milk protein and 100 mg isoflavones
Number of subjects: 180